Chronic hepatitis B or C infection is the most common risk factor for liver cancer1. Together these diseases are estimated to cause up to 80% of liver cancer cases globally2. Studies have shown that the risk of developing liver cancer can be up to 20 times higher in people with chronic hepatitis infection than among the general population3,4.
It has been projected that in 2016, there will be 1,840 new diagnoses and 1,805 deaths due to liver cancer in Australia. In addition, the age-standardised mortality rate for liver cancer has been increasing over time, from 2 deaths per 100,000 persons in 1980 to 6 per 100,000 in 2013 (see NCCI Indicator – Mortality).